Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 12:9:941368.
doi: 10.3389/fsurg.2022.941368. eCollection 2022.

Factors influencing treatment decisions in HIFU treatment of adenomyosis: A retrospective study

Qiao Zhong  1 , Mei-Jie Yang  1   2 , Yan Hu  1 , Li Jiang  1 , Jing-Wen Yu  1 , Jin-Yun Chen  1   3 , Wen-Zhi Chen  1
Affiliations

Factors influencing treatment decisions in HIFU treatment of adenomyosis: A retrospective study

Qiao Zhong et al. Front Surg. .

Abstract

Objective: To explore the influencing factors of decision-making in patients with adenomyosis, who are receiving high-intensity focused ultrasound (HIFU) treatment.

Methods: A total of 776 patients with adenomyosis were enrolled into HIFU group (241 cases) and hysterectomy group (535 cases) according to the treatment methods. The general data, clinical symptoms, marital and childbearing history, and economic status were compared between the two groups, and factors with P < 0.05 were introduced into multivariate logistic regression analysis to determine the determinants of patients choosing HIFU.

Results: The average age of the patients in the HIFU group was 39.1 ± 5.2 years, which was lower than that in the hysterectomy group, which was 45.1 ± 3.9 years (P < 0.05). The basic medical insurance for urban workers in the HIFU group was more than the hysterectomy group (P < 0.05). 95.9% of the hysterectomy group had no desire to have children, compared to 60.6% of the HIFU group, the difference was significant (P < 0.05). The treatment costs of HIFU group were significantly lower than that of hysterectomy group (P < 0.05). The main symptoms of the two groups were dysmenorrhea, menorrhagia, and secondary anemia. The results of multivariate logistic regression analysis showed that 31-40 years old, fertility desire, dysmenorrhea, menorrhagia, anemia and dizziness and fatigue were the influencing factors for the decision-making of HIFU for patients with adenomyosis.

Conclusion: 31-40 years old, fertility desire, dysmenorrhea, menorrhagia, anemia and dizziness and fatigue were the influencing factors for patients to choose HIFU treatment. HIFU therapy has emerged as a new option for patients with adenomyosis as an alternative to hysterectomy.

Keywords: HIFU; adenomyosis; decision-making; dysmenorrhea; menorrhagia.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Mr images obtained from a patient with adenomyosis. (A) T2WI shows a well-defined adenomyosis lesion, which is a poorly defined low-signal lesion with scattered punctate and patchy high-signal foci located in the posterior uterine wall (arrow); (B) Contrast-enhanced MRI showed perfusion of the adenomyotic lesion (arrow); (C) Post-treatment T1-weighted contrast-enhanced image shows that the non-perfused volume ratio was 83.5% (arrow).
Figure 2
Figure 2
Symptoms of patients with adenomyosis (%).
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Donnez J, Donnez O, Dolmans MM. Introduction: uterine adenomyosis, another enigmatic disease of our time. Fertil Steril. (2018) 109(3):369–70. 10.1016/j.fertnstert.2018.01.035 - DOI - PubMed
    1. Senturk LM, Imamoglu M. Adenomyosis: what is new? Women's Health. (2015) 11(5):717–24. 10.2217/whe.15.60 - DOI - PubMed
    1. Protopapas A, Grimbizis G, Athanasiou S, Loutradis D. Adenomyosis: disease, uterine aging process leading to symptoms, or both? Facts, Views Vision in ObGyn. (2020) 12(2):91–104. - PMC - PubMed
    1. Kishi Y, Suginami H, Kuramori R, Yabuta M, Suginami R, Taniguchi F. Four subtypes of adenomyosis assessed by magnetic resonance imaging and their specification. Am J Obstet Gynecol. (2012) 207(2):114.e1–7. 10.1016/j.ajog.2012.06.027 - DOI - PubMed
    1. Van den Bosch T, Van Schoubroeck D. Ultrasound diagnosis of endometriosis and adenomyosis: state of the art. Best Pract Res Clin Obstet Gynaecol. (2018) 51:16–24. 10.1016/j.bpobgyn.2018.01.013 - DOI - PubMed

LinkOut - more resources